Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Aclaris Therapeutics, Inc. (ACRS) had Receiveable Turnover of 104.86 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$31.25M |
|
$-88.48M |
|
$18.08M |
|
$13.17M |
|
$128.61M |
|
$-97.36M |
|
$8.51M |
|
$-88.85M |
|
$-88.85M |
|
$-88.48M |
|
$-88.48M |
|
$-88.48M |
|
$-88.48M |
|
$-97.36M |
|
$-96.49M |
|
69.81M |
|
69.81M |
|
$-1.27 |
|
$-1.27 |
|
| Balance Sheet Financials | |
$128.86M |
|
$1.62M |
|
$68.55M |
|
$197.41M |
|
$30.95M |
|
-- |
|
$9.27M |
|
$40.23M |
|
$157.18M |
|
$156.91M |
|
$157.18M |
|
70.89M |
|
| Cash Flow Statement Financials | |
$-78.33M |
|
$46.22M |
|
$26.71M |
|
$45.28M |
|
$39.88M |
|
$-5.40M |
|
$20.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
42.14% |
|
-311.55% |
|
-311.55% |
|
-308.79% |
|
-284.32% |
|
-283.15% |
|
$-79.63M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
-- |
|
|
Receiveable Turnover |
104.86 |
3.48 |
|
-56.29% |
|
-56.39% |
|
-44.82% |
|
-56.29% |
|
$2.22 |
|
$-1.14 |
|
$-1.12 |
|